US Stock MarketDetailed Quotes

SCLX Scilex Holding

Watchlist

0.971
0.000-0.03%

Trading Nov 4 13:47 ET

186.25MMarket Cap-674P/E (TTM)

Scilex Holding Stock Forum

Clintzilla

5 hours ago

$Scilex Holding (SCLX.US)$ might move better on light volume today

Ultratech

Yesterday 00:10

$Scilex Holding (SCLX.US)$
acquiring insiders

Trytosaveabit

Oct 30 05:23

Update

$Scilex Holding (SCLX.US)$ Scilex Announced It Had A Successful End Of Phase II Meeting With The FDA Leading To An Agreed Path Forward To NDA Upon Completion Of Phase III Trials For Blockbuster Product Candidate, SP-103 (Lidocaine Topical System) 5.4% For The Treatment Of Chronic Neck Pain Associated With Muscle Spasms

Teddy123

Oct 30 05:09

Scilex Pharmaceuticals Inc, a Wholly Owned Subsidiary of Scilex Holding Company, Announces Successful End of Phase II Meeting with FDA Leading to an Agreed Path Forward to NDA Upon Completion of Phase

$Scilex Holding (SCLX.US)$
30/10/2024 - 18:00
Successful end of Phase II meeting with FDA leading to an agreed path forward to NDA upon completion of Phase III trials for blockbuster product candidate, SP-103, for the treatment of chronic neck pain associated with muscle spasms.
SP-103 (lidocaine t...

Trytosaveabit

Oct 29 19:59

New Form 4

$Scilex Holding (SCLX.US)$

Trytosaveabit

Oct 28 05:33

New 8K

$Scilex Holding (SCLX.US)$ Scilex Holding Company sets November 7, 2024 as the Record Date for a Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary
•
Scilex notified NASDAQ on October 28, 2024 that it has set a record date of November 7, 2024 (the “Record Date”) for the dividend of Scilex preferred stock to Scilex’s stockholders and certain other securityholders of Scilex.
•
Based on independen...